Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q2- Text added to 2020 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
affirmed, aggregate, anemia, antidilutive, Antitrust, appellate, appetite, apportionment, authoritative, bleeding, Blenrep, certified, China, Columbia, composition, constrained, contact, conveyance, count, DOR, East, Eastern, esophageal, freestanding, gallbladder, gastric, gastroesophageal, hormone, Latin, LV, Middle, mild, neutrophil, nurse, ocular, onsite, overruled, oxaliplatin, paclitaxel, premium, prepayment, proportionately, ramucirumab, refrain, regular, reliant, restraint, septic, shock, subsidiary, text, tracing, TUKSYA, twenty, usage, waiting, wholly
Valuein 2020 Q2 filing- Value in 2020 Q3 filing
Original filings
Filing view